Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Xeloda
Routinely available
SMC (507/08)
01/08/2009
Indication
Metastatic colorectal cancer
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
150mg, 500mg tablets
Comments
August 2009 - Added to the Additional List – for Specialist Use only.